Radiation Treatment with New Drugs for Metastatic Breast Cancer
Concomitant Radiotherapy and New Drugs in Metastatic Breast Cancer
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 300 (estimated)
- Sponsor
- Fondazione Policlinico Universitario Campus Bio-Medico · Other
This trial is looking for patients with stage IV breast cancer who are receiving new drug treatments. Participants will undergo radiation therapy while continuing their treatment to see how well they tolerate it.
You may be able to join if
- I have stage IV breast cancer
- I am receiving systemic treatment with new drugs
- I am eligible for radiation treatment
You may not be able to join if
- I have had previous radiation treatment on the same site
- I have absolute contraindications to radiotherapy
- I am receiving systemic treatment as part of a clinical trial
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your EligibilityThe primary objective of the study is to describe the tolerance profile of radiation treatments performed during systemic treatment with new drugs (molecular targeted therapies, immunotherapy, others).
Loading trial locations…